Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study

Cell-Free DNA to Detect Heart Allograft Acute Rejection

(2021) Sean Agbor-Enoh et al.   CIRCULATION

Intensity of de novo DSA detected by Immucor Lifecodes assay and C3d fixing antibodies are not predictive of subclinical ABMR after Kidney Transplantation

(2021) Dominique Bertrand et al.   PLoS One

Longitudinal variance of Donor‐Derived Cell‐Free DNA (dd‐cfDNA) in Stable Kidney Transplant (KTx) patients are influenced by donor/recipient variables

(2021) Sanjiv Anand et al.   CLINICAL TRANSPLANTATION

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection

(2021) Marta Crespo et al.   Frontiers in Immunology

Utility of Donor-Derived Cell-Free DNA in Detecting ABMR in Patients With AT1R Antibodies

(2021) Sam Kant et al.   Kidney International Reports

High levels of dd‐cfDNA identifies patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury

(2020) Erik Stites et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Adding Insult on Injury

(2020) Shamik Dholakia et al.   TRANSPLANTATION

Early clinical experience using donor‐derived cell‐free DNA to detect rejection in kidney transplant recipients

(2019) Edmund Huang et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Donor-derived Cell–free DNA May Confirm Real-time Response to Treatment of Acute Rejection in Renal Transplant Recipients

(2019) Randall J. Hinojosa et al.   TRANSPLANTATION

Protocol Biopsies in Patients with Subclinical De Novo DSA After Kidney Transplantation

(2019) Dominique Bertrand et al.   TRANSPLANTATION

Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis

(2018) Sean Agbor-Enoh et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes

(2018) Geovani Faddoul et al.   TRANSPLANTATION

Donor-specific Cell-Free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review

(2018) Simon R. Knight et al.   TRANSPLANTATION

Cell-Free DNA and Active Rejection in Kidney Allografts

(2017) Roy D. Bloom et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen

(2017) Daniel Zecher et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients

(2016) Marica Grskovic et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Relationship between eGFR Decline and Hard Outcomes after Kidney Transplants

(2016) P. A. Clayton et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Calculation of limits for significant unidirectional changes in two or more serial results of a biomarker based on a computer simulation model

(2015) Flemming Lund et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Incidence and Clinical Significance ofDe NovoDonor Specific Antibodies after Kidney Transplantation

(2013) Sophia Lionaki et al.   Clinical & Developmental Immunology

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

(2013) Alexandre Loupy et al.   NEW ENGLAND JOURNAL OF MEDICINE